Vertex Pharmaceuticals Tax Reconciliation, Foreign Rate Differential remained flat by 0.0% to $0.05 in Q4 2024 compared to the prior quarter. Year-over-year, this metric grew by 3650.0%, from -$0.00 to $0.05. This is a positive signal — higher values indicate stronger performance for this metric.
A positive differential suggests the company benefits from lower-tax foreign jurisdictions, improving overall net margins.
This metric measures the impact on the effective tax rate caused by the difference between the domestic statutory tax ra...
A critical metric for global enterprises to explain deviations from the statutory tax rate.
is_cop_tax_reconciliation_foreign_rate_differential| FY'23 | FY'24 | |
|---|---|---|
| Value | -$0.01 | $0.21 |
| YoY Change | — | >999% |
We use cookies for analytics. See our Privacy and Cookie Policy.